Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Influenza

  Free Subscription


27.07.2020

7 Ann Intern Med
1 Antiviral Res
2 Arch Virol
15 BMJ
1 Cell
6 Epidemiol Infect
2 J Exp Med
5 J Infect Dis
2 J Virol
1 J Virol Methods
4 JAMA
3 Lancet
3 Lancet Gastroenterol Hepatol
5 Lancet Oncol
2 Lancet Planet Health
5 MMWR Morb Mortal Wkly Rep
6 N Engl J Med
1 Pediatrics
2 PLoS Comput Biol
1 PLoS Med
9 PLoS One
9 Proc Natl Acad Sci U S A
8 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Intern Med

  1. WEISSMAN GE, Crane-Droesch A, Chivers C, Luong T, et al
    Locally Informed Simulation to Predict Hospital Capacity Needs During the COVID-19 Pandemic.
    Ann Intern Med. 2020 Apr 7. pii: 2764423. doi: 10.7326/M20-1260.
    PubMed         Abstract available

  2. ALEXANDER GC, Stoller KB, Haffajee RL, Saloner B, et al
    An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19.
    Ann Intern Med. 2020 Apr 2. pii: 2764311. doi: 10.7326/M20-1141.
    PubMed        

  3. BECKER WC, Fiellin DA
    When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis.
    Ann Intern Med. 2020 Apr 2. pii: 2764312. doi: 10.7326/M20-1210.
    PubMed        

  4. VOLKOW ND
    Collision of the COVID-19 and Addiction Epidemics.
    Ann Intern Med. 2020 Apr 2. pii: 2764313. doi: 10.7326/M20-1212.
    PubMed        

  5. WOOLHANDLER S, Himmelstein DU
    Intersecting U.S. Epidemics: COVID-19 and Lack of Health Insurance.
    Ann Intern Med. 2020 Apr 7. pii: 2764415. doi: 10.7326/M20-1491.
    PubMed        

  6. QASEEM A, Yost J, Etxeandia-Ikobaltzeta I, Miller MC, et al
    Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians.
    Ann Intern Med. 2020 Jun 17. doi: 10.7326/M20-3862.
    PubMed        

  7. CENTOR RM, Kumfer AM, Shekarchian S
    Annals On Call - Clinical Reasoning and COVID-19 Part 2.
    Ann Intern Med. 2020 Jun 23:OC1. doi: 10.7326/A19-0033.
    PubMed        


    Antiviral Res

  8. CAI W, Wen H, Zhou Q, Wu L, et al
    14-Deoxy-11,12-didehydroandrographolide inhibits apoptosis in influenza A(H5N1) virus-infected human lung epithelial cells via the caspase-9-dependent intrinsic apoptotic pathway which contributes to its antiviral activity.
    Antiviral Res. 2020 Jul 20:104885. doi: 10.1016/j.antiviral.2020.104885.
    PubMed         Abstract available


    Arch Virol

  9. MCIVER DJ, Silithammavong S, Theppangna W, Gillis A, et al
    Coronavirus surveillance of wildlife in the Lao People's Democratic Republic detects viral RNA in rodents.
    Arch Virol. 2020;165:1869-1875.
    PubMed         Abstract available

  10. LIMA WG, Brito JCM, Overhage J, Nizer WSDC, et al
    The potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2): a systematic review.
    Arch Virol. 2020;165:1729-1737.
    PubMed         Abstract available


    BMJ

  11. TATUM M
    Will medical tourism survive covid-19?
    BMJ. 2020;370:m2677.
    PubMed        

  12. TING R, Edmonds P, Higginson IJ, Sleeman KE, et al
    Palliative care for patients with severe covid-19.
    BMJ. 2020;370:m2710.
    PubMed        

  13. REINTJES R
    Lessons in contact tracing from Germany.
    BMJ. 2020;369:m2522.
    PubMed        

  14. NEAL RD, Nekhlyudov L, Wheatstone P, Koczwara B, et al
    Cancer care during and after the pandemic.
    BMJ. 2020;370:m2622.
    PubMed        

  15. MARCHETTI F, Tamburlini G
    Time to go back to school: several good reasons beyond low infection risk.
    BMJ. 2020;370:m2625.
    PubMed        

  16. CHODOSH J, Weinstein BE, Blustein J
    Face masks can be devastating for people with hearing loss.
    BMJ. 2020;370:m2683.
    PubMed        

  17. MOYNIHAN R, Johansson M, Maybee A, Lang E, et al
    Covid-19: an opportunity to reduce unnecessary healthcare.
    BMJ. 2020;370:m2752.
    PubMed        

  18. AHMED SI, Hasan SMT, Ahmed T
    Obesity is a potential risk factor for covid-19 associated morbidity and mortality in urban Bangladesh.
    BMJ. 2020;370:m2811.
    PubMed        

  19. SINGH A
    Covid-19: disinfectants and sanitisers are changing microbiomes.
    BMJ. 2020;370:m2795.
    PubMed        

  20. ENGLAND R
    Ethnicity and covid-19: working locally to reduce inequalities.
    BMJ. 2020;370:m2748.
    PubMed        

  21. GLYNN JR, Fielding K, Shakespeare T, Campbell O, et al
    Covid-19: excess all cause mortality in domiciliary care.
    BMJ. 2020;370:m2751.
    PubMed        

  22. VAN DE GRAAF RC, Hofstra L
    Obesity and covid-19: the role of the food industry.
    BMJ. 2020;370:m2813.
    PubMed        

  23. MAY T
    Lockdown-type measures look effective against covid-19.
    BMJ. 2020;370:m2809.
    PubMed        

  24. GREEN L, Wood S, Bellis MA
    Rising to the triple challenge of covid-19, Brexit, and climate change.
    BMJ. 2020;370:m2798.
    PubMed        

  25. SHEATHER J, Hartwell A, Norcliffe-Brown D
    Serious violations of health workers' rights during pandemic.
    BMJ. 2020;370:m2824.
    PubMed        


    Cell

  26. JOYCE MG, Wheatley AK, Modjarrad K
    Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks.
    Cell. 2020;182:7-9.
    PubMed         Abstract available


    Epidemiol Infect

  27. QI C, Zhu YC, Li CY, Hu YC, et al
    Epidemiological characteristics and spatial-temporal analysis of COVID-19 in Shandong Province, China.
    Epidemiol Infect. 2020;148:e141.
    PubMed         Abstract available

  28. SUN Y, Tian L, Du X, Wang H, et al
    Epidemiological and clinical characteristics of a familial cluster of COVID-19.
    Epidemiol Infect. 2020;148:e145.
    PubMed         Abstract available

  29. KONG M, Zhang H, Cao X, Mao X, et al
    Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19.
    Epidemiol Infect. 2020;148:e139.
    PubMed         Abstract available

  30. WENG CH, Saal A, Butt WW, Bica N, et al
    Bacillus Calmette-Guerin vaccination and clinical characteristics and outcomes of COVID-19 in Rhode Island, United States: a cohort study.
    Epidemiol Infect. 2020;148:e140.
    PubMed         Abstract available

  31. LI J, Ding J, Chen L, Hong L, et al
    Epidemiological and clinical characteristics of three family clusters of COVID-19 transmitted by latent patients in China.
    Epidemiol Infect. 2020;148:e137.
    PubMed         Abstract available

  32. FENG X, Ding X, Zhang F
    Dynamic evolution of lung abnormalities evaluated by quantitative CT techniques in patients with COVID-19 infection.
    Epidemiol Infect. 2020;148:e136.
    PubMed         Abstract available


    J Exp Med

  33. NATHAN C
    Neutrophils and COVID-19: Nots, NETs, and knots.
    J Exp Med. 2020;217.
    PubMed         Abstract available

  34. KOENIG LM, Boehmer DFR, Metzger P, Schnurr M, et al
    Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19.
    J Exp Med. 2020;217.
    PubMed         Abstract available


    J Infect Dis

  35. TRAUGOTT M, Aberle SW, Aberle JH, Griebler H, et al
    Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests.
    J Infect Dis. 2020;222:362-366.
    PubMed         Abstract available

  36. HAO S, Lian J, Lu Y, Jia H, et al
    Decreased B Cells on Admission Associated With Prolonged Viral RNA Shedding From the Respiratory Tract in Coronavirus Disease 2019: A Case-Control Study.
    J Infect Dis. 2020;222:367-371.
    PubMed         Abstract available

  37. SINGH JA
    The case for why Africa should host COVID-19 candidate vaccine trials.
    J Infect Dis. 2020 Jun 3. pii: 5850913. doi: 10.1093.
    PubMed         Abstract available

  38. ATMAR RL, Keitel WA
    Searching for Improved Flu Vaccines - The Time Is Now.
    J Infect Dis. 2019 Oct 30. pii: 5609442. doi: 10.1093.
    PubMed        

  39. LARGENT EA, Lynch HF
    Paying Participants in COVID-19 Trials.
    J Infect Dis. 2020;222:356-361.
    PubMed         Abstract available


    J Virol

  40. CHANG P, Sealy JE, Sadeyen JR, Bhat S, et al
    Immune escape adaptive mutations in the H7N9 avian influenza hemagglutinin protein increase virus replication fitness and decrease pandemic potential.
    J Virol. 2020 Jul 22. pii: JVI.00216-20. doi: 10.1128/JVI.00216.
    PubMed         Abstract available

  41. OSTBYE H, Gao J, Rakic Martinez M, Wang H, et al
    N-linked glycan sites on the influenza NA head domain are required for efficient IAV incorporation and replication.
    J Virol. 2020 Jul 22. pii: JVI.00874-20. doi: 10.1128/JVI.00874.
    PubMed         Abstract available


    J Virol Methods

  42. WANG P
    Combination of serological total antibody and RT-PCR test for detection of SARS-COV-2 infections.
    J Virol Methods. 2020;283:113919.
    PubMed         Abstract available


    JAMA

  43. MURPHY K, Koski-Vacirca R, Sharfstein J
    Resilience in Health Care Financing.
    JAMA. 2020;324:126-127.
    PubMed        

  44. ABBASI J
    Researchers Home in on COVID-19 Severity Biomarkers.
    JAMA. 2020;324:128.
    PubMed        

  45. ABBASI J
    COVID-19 Antibody Trials Have Begun.
    JAMA. 2020;324:128.
    PubMed        

  46. BAUD D
    Calculation Error in Study of Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain.
    JAMA. 2020;324:304-305.
    PubMed        


    Lancet

  47. KING A, Andrus JK, Figueroa JP
    Financial crisis at PAHO in the time of COVID-19: a call for action.
    Lancet. 2020 Jul 2. pii: S0140-6736(20)31489.
    PubMed        

  48. KING T, Hewitt B, Crammond B, Sutherland G, et al
    Reordering gender systems: can COVID-19 lead to improved gender equality and health?
    Lancet. 2020 Jun 19. pii: S0140-6736(20)31418.
    PubMed        

  49. TAYLOR AL, Habibi R, Burci GL, Dagron S, et al
    Solidarity in the wake of COVID-19: reimagining the International Health Regulations.
    Lancet. 2020 Jun 19. pii: S0140-6736(20)31417.
    PubMed        


    Lancet Gastroenterol Hepatol

  50. GIANNONI E, Baud D, Agri VD, Gibson GR, et al
    Probiotics and COVID-19.
    Lancet Gastroenterol Hepatol. 2020;5:720-721.
    PubMed        

  51. CECCARELLI G, Scagnolari C, Pugliese F, Mastroianni CM, et al
    Probiotics and COVID-19.
    Lancet Gastroenterol Hepatol. 2020;5:721-722.
    PubMed        

  52. MAK JWY, Chan FKL, Ng SC
    Probiotics and COVID-19 - Authors' reply.
    Lancet Gastroenterol Hepatol. 2020;5:722-723.
    PubMed        


    Lancet Oncol

  53. TIU C, Shinde R, Yap C, Rao Baikady B, et al
    A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic.
    Lancet Oncol. 2020;21:889-891.
    PubMed        

  54. GARASSINO MC, Whisenant JG, Huang LC, Trama A, et al
    COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
    Lancet Oncol. 2020 Jun 12. pii: S1470-2045(20)30314.
    PubMed         Abstract available

  55. MEHANNA H, Hardman JC, Shenson JA, Abou-Foul AK, et al
    Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus.
    Lancet Oncol. 2020 Jun 11. pii: S1470-2045(20)30334.
    PubMed         Abstract available

  56. TIAN J, Yuan X, Xiao J, Zhong Q, et al
    Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study.
    Lancet Oncol. 2020 May 29. pii: S1470-2045(20)30309.
    PubMed         Abstract available

  57. YANG K, Sheng Y, Huang C, Jin Y, et al
    Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
    Lancet Oncol. 2020 May 29. pii: S1470-2045(20)30310.
    PubMed         Abstract available


    Lancet Planet Health

  58. ACHEBAK H, Petetin H, Quijal-Zamorano M, Bowdalo D, et al
    Reduction in air pollution and attributable mortality due to COVID-19 lockdown.
    Lancet Planet Health. 2020;4:e268.
    PubMed        

  59. CHEN K, Wang M, Kinney PL, Anastas PT, et al
    Reduction in air pollution and attributable mortality due to COVID-19 lockdown - Authors' reply.
    Lancet Planet Health. 2020;4:e269.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  60. BURKE RM, Killerby ME, Newton S, Ashworth CE, et al
    Symptom Profiles of a Convenience Sample of Patients with COVID-19 - United States, January-April 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:904-908.
    PubMed         Abstract available

  61. WORTHAM JM, Lee JT, Althomsons S, Latash J, et al
    Characteristics of Persons Who Died with COVID-19 - United States, February 12-May 18, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:923-929.
    PubMed         Abstract available

  62. HENDRIX MJ, Walde C, Findley K, Trotman R, et al
    Absence of Apparent Transmission of SARS-CoV-2 from Two Stylists After Exposure at a Hair Salon with a Universal Face Covering Policy - Springfield, Missouri, May 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:930-932.
    PubMed         Abstract available

  63. FISHER KA, Barile JP, Guerin RJ, Vanden Esschert KL, et al
    Factors Associated with Cloth Face Covering Use Among Adults During the COVID-19 Pandemic - United States, April and May 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:933-937.
    PubMed         Abstract available

  64. BUSHMAN D, Alroy KA, Greene SK, Keating P, et al
    Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:918-922.
    PubMed         Abstract available


    N Engl J Med

  65. EL-SADR WM, Justman J
    Africa in the Path of Covid-19.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMp2008193.
    PubMed        

  66. ZAGURY-ORLY I, Schwartzstein RM
    Covid-19 - A Reminder to Reason.
    N Engl J Med. 2020 Apr 28. doi: 10.1056/NEJMp2009405.
    PubMed        

  67. BOWLES L, Platton S, Yartey N, Dave M, et al
    Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.
    N Engl J Med. 2020 May 5. doi: 10.1056/NEJMc2013656.
    PubMed        

  68. CHOWKWANYUN M, Reed AL Jr
    Racial Health Disparities and Covid-19 - Caution and Context.
    N Engl J Med. 2020 May 6. doi: 10.1056/NEJMp2012910.
    PubMed        

  69. SPRING LM, Specht MC, Jimenez RB, Isakoff SJ, et al
    Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic.
    N Engl J Med. 2020 Jul 1. doi: 10.1056/NEJMcpc2002422.
    PubMed        

  70. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 Vaccine Development.
    N Engl J Med. 2020;383:e40.
    PubMed        


    Pediatrics

  71. MUCHMORE B, Muchmore P, Wing Lee C, Alarcon-Riquelme ME, et al
    Tracking Potential COVID-19 Outbreaks With Influenza-Like Symptoms Urgent Care Visits.
    Pediatrics. 2020 Jul 22. pii: peds.2020-1798. doi: 10.1542/peds.2020-1798.
    PubMed        


    PLoS Comput Biol

  72. HILTON J, Keeling MJ
    Estimation of country-level basic reproductive ratios for novel Coronavirus (SARS-CoV-2/COVID-19) using synthetic contact matrices.
    PLoS Comput Biol. 2020;16:e1008031.
    PubMed         Abstract available

  73. PARAG KV, Donnelly CA
    Using information theory to optimise epidemic models for real-time prediction and estimation.
    PLoS Comput Biol. 2020;16:e1007990.
    PubMed         Abstract available


    PLoS Med

  74. SAVICKAS V, Stewart AJ, Rees-Roberts M, Short V, et al
    Opportunistic screening for atrial fibrillation by clinical pharmacists in UK general practice during the influenza vaccination season: A cross-sectional feasibility study.
    PLoS Med. 2020;17:e1003197.
    PubMed         Abstract available


    PLoS One

  75. KLINK T, Rankin DA, Piya B, Spieker AJ, et al
    Evaluating the diagnostic accuracy of the WHO Severe Acute Respiratory Infection (SARI) criteria in Middle Eastern children under two years over three respiratory seasons.
    PLoS One. 2020;15:e0232188.
    PubMed         Abstract available

  76. MONAMELE CG, Kengne-Nde C, Munshili Njifon HL, Njankouo MR, et al
    Clinical signs predictive of influenza virus infection in Cameroon.
    PLoS One. 2020;15:e0236267.
    PubMed         Abstract available

  77. MAMODE KHAN N, Soobhug AD, Heenaye-Mamode Khan M
    Studying the trend of the novel coronavirus series in Mauritius and its implications.
    PLoS One. 2020;15:e0235730.
    PubMed         Abstract available

  78. QIAN K, Yahara T
    Mentality and behavior in COVID-19 emergency status in Japan: Influence of personality, morality and ideology.
    PLoS One. 2020;15:e0235883.
    PubMed         Abstract available

  79. GIETEMA HA, Zelis N, Nobel JM, Lambriks LJG, et al
    CT in relation to RT-PCR in diagnosing COVID-19 in The Netherlands: A prospective study.
    PLoS One. 2020;15:e0235844.
    PubMed         Abstract available

  80. ZHANG B, Zhou X, Qiu Y, Song Y, et al
    Clinical characteristics of 82 cases of death from COVID-19.
    PLoS One. 2020;15:e0235458.
    PubMed         Abstract available

  81. LENZEN M, Li M, Malik A, Pomponi F, et al
    Global socio-economic losses and environmental gains from the Coronavirus pandemic.
    PLoS One. 2020;15:e0235654.
    PubMed         Abstract available

  82. MORA O, Le Mouel C, de Lattre-Gasquet M, Donnars C, et al
    Exploring the future of land use and food security: A new set of global scenarios.
    PLoS One. 2020;15:e0235597.
    PubMed         Abstract available

  83. PEIXOTO PS, Marcondes D, Peixoto C, Oliva SM, et al
    Modeling future spread of infections via mobile geolocation data and population dynamics. An application to COVID-19 in Brazil.
    PLoS One. 2020;15:e0235732.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  84. BONACCORSI G, Pierri F, Cinelli M, Flori A, et al
    Economic and social consequences of human mobility restrictions under COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:15530-15535.
    PubMed         Abstract available

  85. ZHANG R, Li Y, Zhang AL, Wang Y, et al
    Identifying airborne transmission as the dominant route for the spread of COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:14857-14863.
    PubMed         Abstract available

  86. YAO Y, Kadam RU, Lee CD, Woehl JL, et al
    An influenza A hemagglutinin small-molecule fusion inhibitor identified by a new high-throughput fluorescence polarization screen.
    Proc Natl Acad Sci U S A. 2020 Jul 20. pii: 2006893117.
    PubMed         Abstract available

  87. SIEGENFELD AF, Taleb NN, Bar-Yam Y
    Opinion: What models can and cannot tell us about COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:16092-16095.
    PubMed        

  88. LAMMERS J, Crusius J, Gast A
    Correcting misperceptions of exponential coronavirus growth increases support for social distancing.
    Proc Natl Acad Sci U S A. 2020;117:16264-16266.
    PubMed         Abstract available

  89. ESTEVE A, Permanyer I, Boertien D, Vaupel JW, et al
    National age and coresidence patterns shape COVID-19 vulnerability.
    Proc Natl Acad Sci U S A. 2020;117:16118-16120.
    PubMed         Abstract available

  90. IMAI M, Iwatsuki-Horimoto K, Hatta M, Loeber S, et al
    Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.
    Proc Natl Acad Sci U S A. 2020;117:16587-16595.
    PubMed         Abstract available

  91. MALISCH JL, Harris BN, Sherrer SM, Lewis KA, et al
    Opinion: In the wake of COVID-19, academia needs new solutions to ensure gender equity.
    Proc Natl Acad Sci U S A. 2020;117:15378-15381.
    PubMed        

  92. BENZELL SG, Collis A, Nicolaides C
    Rationing social contact during the COVID-19 pandemic: Transmission risk and social benefits of US locations.
    Proc Natl Acad Sci U S A. 2020;117:14642-14644.
    PubMed         Abstract available


    Vaccine

  93. HENN W
    Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity.
    Vaccine. 2020 Jun 23. pii: S0264-410X(20)30844.
    PubMed        

  94. SAUNIER F, Berthelot P, Mottet-Auselo B, Pelissier C, et al
    Impact of a decision-aid tool on influenza vaccine coverage among HCW in two French hospitals: A cluster-randomized trial.
    Vaccine. 2020 Jul 16. pii: S0264-410X(20)30911.
    PubMed         Abstract available

  95. SKARLUPKA AL, Handel A, Ross TM
    Influenza hemagglutinin antigenic distance measures capture trends in HAI differences and infection outcomes, but are not suitable predictive tools.
    Vaccine. 2020 Jul 15. pii: S0264-410X(20)30828.
    PubMed         Abstract available

  96. JUNG YJ, Kim KH, Ko EJ, Lee Y, et al
    Adjuvant effects of killed Lactobacillus casei DK128 on enhancing T helper type 1 immune responses and the efficacy of influenza vaccination in normal and CD4-deficient mice.
    Vaccine. 2020 Jul 13. pii: S0264-410X(20)30878.
    PubMed         Abstract available

  97. GARCIA LY, Cerda AA
    Contingent assessment of the COVID-19 vaccine.
    Vaccine. 2020 Jun 25. pii: S0264-410X(20)30854.
    PubMed         Abstract available

  98. VEKEMANS J, Moorthy V, Giersing B, Friede M, et al
    Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics.
    Vaccine. 2018 Jan 25. pii: S0264-410X(17)31364.
    PubMed         Abstract available

  99. KARTOGLU UH, Moore KL, Lloyd JS
    Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers.
    Vaccine. 2020 Jun 23. pii: S0264-410X(20)30842.
    PubMed        

  100. PAGLIUSI S, Jarrett S, Hayman B, Kreysa U, et al
    Emerging manufacturers engagements in the COVID -19 vaccine research, development and supply.
    Vaccine. 2020 Jun 11. pii: S0264-410X(20)30795.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: